Pharmacology

Action Mechanism of Action Reference
AGONIST Erythropoietin receptor agonist FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Anemia 4 D000740 ClinicalTrials
HIV Infections 4 D015658 ClinicalTrials
Uterine Cervical Neoplasms 3 D002583 ClinicalTrials
Kidney Failure, Chronic 3 D007676 ClinicalTrials
Leukemia, Myelomonocytic, Chronic 3 D015477 ClinicalTrials
Fatigue 3 D005221 ClinicalTrials
Hepatitis C 3 D006526 ClinicalTrials
Brain Ischemia 3 D002545 ClinicalTrials
Breast Neoplasms 3 D001943 ClinicalTrials
Lung Neoplasms 3 D008175 ClinicalTrials
Brain Injuries 3 D001930 ClinicalTrials
Myelodysplastic Syndromes 3 D009190 ClinicalTrials
Ovarian Neoplasms 3 D010051 ClinicalTrials
Head and Neck Neoplasms 3 D006258 ClinicalTrials
Venous Thrombosis 3 D020246 ClinicalTrials
Prostatic Neoplasms 3 D011471 ClinicalTrials
Leukemia, Myeloid, Acute 3 D015470 ClinicalTrials
Peritoneal Neoplasms 3 D010534 ClinicalTrials
Heart Arrest 3 D006323 ClinicalTrials
Premature Birth 2 D047928 ClinicalTrials
Friedreich Ataxia 2 D005621 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Stroke 2 D020521 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Peripheral Nervous System Diseases 2 D010523 ClinicalTrials
beta-Thalassemia 2 D017086 ClinicalTrials
ST Elevation Myocardial Infarction 2 D000072657 ClinicalTrials
Anemia, Neonatal 2 D000751 ClinicalTrials
Coronary Disease 2 D003327 ClinicalTrials
Myocardial Infarction 2 D009203 ClinicalTrials
Substance-Related Disorders 1 D019966 ClinicalTrials
Diabetic Foot 1 D017719 ClinicalTrials
Asphyxia 1 D001237 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1201565